Primer probe combination for detecting iPSC residues in HEK293 cells and application of primer probe combination
By designing primer-probe combinations targeting the SFRP2 and ZSCAN10 genes and combining them with qPCR detection, the sensitivity and accuracy issues of iPSC residual detection in HEK293 cells were resolved, achieving a detection sensitivity of 0.0001%, thus improving the safety and reliability of iPSC-derived cell therapy products.
Patent Information
- Application Number
- CN202411249899.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-06
- Publication Date
- 2024-11-01
AI Technical Summary
Existing technologies are difficult to detect iPSC residues in HEK293 cells efficiently and sensitively, posing risks of false negatives and false positives. Furthermore, the procedures are complex and costly, limiting the safety and reliability of iPSC-derived cell therapy products.
A specific primer-probe combination was designed to target the SFRP2 and ZSCAN10 gene fragments. Combined with qPCR detection, dye and probe methods were used to achieve highly sensitive detection of iPSC remnants in HEK293 cells, reaching a detection sensitivity of 0.0001%.
This study achieved highly sensitive detection of iPSC remnants in HEK293 cells, capable of distinguishing one iPSC remnant from 1×106 cells, thus improving detection accuracy and efficiency while reducing detection costs.
Smart Images

Figure CN118879879A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of pluripotent stem cell residue detection in biological products, and in particular to a primer probe combination and application thereof for detecting iPSC residues in HEK293 cells. Background Art
[0002] Induced pluripotent stem cells (iPSCs) are cells that are artificially introduced with transcription factors or small molecule combinations to return the cells to an undifferentiated state, resulting in a cell type similar to embryonic stem cells (ESCs). The sources of iPSCs are very wide, and almost all cells in the human body can be reprogrammed into iPSCs. iPSCs can circumvent the ethical issues associated with the use of embryonic stem cells and have broad application prospects. Therefore, iPSC technology has been widely used in basic research, disease models, and drug screening, and is an important tool for personalized cell therapy and regenerative medicine research.
[0003] Currently, many iPSC-derived cell therapy products have entered the clinical trial stage, including mesenchymal stem cells, cardiomyocytes, dopaminergic neural precursor cells, retinal pigment epithelial cells, natural killer cells, etc. Various kidney diseases - hereditary kidney disease, acute kidney disease, chronic kidney disease, are killers that affect human health, and iPSC-derived kidney cells (or kidney organoids) have become a potential treatment for them. However, in actual applications, due to its ability to proliferate indefinitely, the undifferentiated cells such as iPSCs remaining in cell therapy products will have the risk of forming teratomas, threatening the success of treatment and the life and health of patients, and becoming the biggest obstacle to its clinical transformation. Therefore, it is necessary to develop an efficient and sensitive method for detecting iPSC residual cells to ensure the safety and reliability of iPSC-derived cell therapy products.
[0004] At present, the common methods for detecting iPSC residues include culture method, immunofluorescence staining method, flow cytometry detection method and real-time fluorescence quantitative PCR (qPCR) / digital PCR (ddPCR). The culture method mainly uses efficient culture technology to make single residual iPSC cells form clones with clear edges. When observed under a high-power microscope, they are clearly distinguished from the surrounding somatic cells. The proportion of iPSC residual cells can be determined by counting the clones. However, the culture cycle is too long, generally requiring 7-10 days of detection time; during the culture process, some cells will spontaneously differentiate, and when the cell planting concentration is too low, iPSC cells are not easy to survive, which will lead to false negative results.
[0005] Immunofluorescence staining is based on the reaction principle of antigen-antibody binding. Cells are planted in a culture plate at an appropriate density and stained with iPSC cell-specific antibodies to locate iPSC cells. However, when the antibody specificity is not high, false positive results will result; when the cell planting density is too low, false negative results are likely to result.
[0006] Flow cytometry is a quantitative method for detecting residual iPSC cells using flow cytometry. In order to remove the background of non-specific binding with antibodies, the specificity of antibodies is required to be high, and the sensitivity of this method can generally only reach about 1%.
[0007] Real-time fluorescence quantitative PCR (qPCR) or digital PCR (ddPCR) detects the expression of specific marker genes in iPSC cells and interprets the difference in expression levels to determine the proportion of residual iPSC cells. Among the currently reported iPSC residual cell detection methods, quantitative PCR has the advantages of simple operation, short time consumption and high sensitivity. And with the development of digital PCR technology, the minimum detection limit of iPSC residues has been further improved. However, these two methods are complicated to operate and have high requirements for experimental personnel and laboratory equipment, which invisibly increases the detection cost and is not conducive to the large-scale application of iPSC residual detection.
[0008] HEK293 cells are a human renal epithelial cell line derived from human embryonic kidney cells. They are a commonly used tool cell line for expressing and studying the functions of exogenous genes. HEK293 cells have the characteristics of high transfection efficiency and easy culture. They rarely express endogenous receptors required for extracellular ligands and are relatively easy to transfect. As human embryonic kidney cells, the iPSC residual detection method in HEK293 can provide an important reference for the detection of iPSC residuals in iPSC-derived kidney cells. So far, no more sensitive detection method for iPSC residuals in human kidney cells HEK293 has been found based on real-time fluorescence quantitative PCR or immunofluorescence staining. Summary of the invention
[0009] The present invention provides a primer-probe combination for detecting iPSC residues in HEK293 cells and its application. For the marker SFRP2 and ZSCAN10 gene fragments, corresponding detection primers and probes are designed respectively, the cell RNA in the sample is extracted for reverse transcription, the cDNA is subjected to qPCR, the detection primers are used for detection by dye method, and the detection primers and probes are combined for detection by probe method, and finally the detection sensitivity of 0.0001% is achieved. It is specifically realized by the following technologies.
[0010] In a first aspect, the present invention provides a method for detecting residual iPSCs in HEK293 cells, comprising the steps of: Extracting RNA from cells in the sample to be tested, reverse transcribing the RNA to obtain reverse transcription product cDNA, and performing qPCR amplification on the cDNA; Design a first primer combination and a first probe for detecting the gene SFRP2, design a second primer combination and a second probe for detecting the gene ZSCAN10, and design a third primer combination and a third probe for detecting the internal reference gene GAPDH; The expression of the gene SFRP2 in the qPCR amplification product is detected using the first primer combination and the first probe, or the expression of the gene ZSCAN10 in the qPCR amplification product is detected using the second primer combination and the second probe; the expression of the internal reference gene GAPDH in the qPCR amplification product is detected using the third primer combination and the third probe; The expression levels of SFRP2 or ZSCAN10 in the sample to be tested and the HEK293 cell standard were calculated, and the gene GAPDH was used as the internal reference gene to compare the expression difference of SFRP2 or ZSCAN10 between the sample to be tested and the HEK293 cell standard to determine the residual situation of iPSC in the sample to be tested; The nucleotide sequence of the first forward primer of the first primer combination is shown as SEQ ID NO.1, and the nucleotide sequence of the first reverse primer is shown as SEQ ID NO.2; the nucleotide sequence of the second forward primer of the second primer combination is shown as SEQ ID NO.3, and the nucleotide sequence of the second reverse primer is shown as SEQ ID NO.4; the nucleotide sequence of the third forward primer of the third primer combination is shown as SEQ ID NO.5, and the nucleotide sequence of the third reverse primer is shown as SEQ ID NO.6.
[0011] In the above method for detecting iPSC residues in HEK293 cells of the present invention, corresponding primer combinations (forward and reverse primers) and probes are designed for the gene SFRP2 or ZSCAN10. The amplification curve and Ct value of the gene SFRP2 or ZSCAN10 in the sample to be tested are obtained by qPCR amplification method, and the amount of iPSC residues in HEK293 cells is determined by comparing the Ct values. When the dye method is used, only the primer combination is needed; when the probe method is used, the probe is also needed.
[0012] It is easy to know that the 5' segment of the nucleotide sequence of the probe is linked to a fluorescent group, and the 3' segment is linked to a quencher group.
[0013] Both the fluorescent group and the quenching group are commonly used groups in the art. Optionally, the fluorescent group can be selected from but not limited to FAM, TET, NED, ROX, CY3, CY5, VIC, JOE, HEX, Texas RED or LC RED460. The quenching group can be selected from but not limited to MGB, TAMRA, NFQ, ECLIPSE, DABCYL, BHQ1 or BHQ2.
[0014] Furthermore, when the dye method is used for detection, the first primer combination is used to detect the expression of the SFRP2 gene, or the second primer combination is used to detect the expression of the gene ZSCAN10; the third primer combination is used to detect the expression of the internal reference gene GAPDH; When the probe method is used for detection, the first primer combination and the first probe are used to detect the expression of the gene SFRP2, or the second primer combination and the second probe are used to detect the expression of the gene ZSCAN10; the third primer combination and the third probe are used to detect the expression of the internal reference gene GAPDH; the nucleotide sequence of the first probe is shown in SEQ ID NO.7, the nucleotide sequence of the second probe is shown in SEQ ID NO.8, and the nucleotide sequence of the third probe is shown in SEQ ID NO.9.
[0015] When the dye method is used for further detection, the HEK293 cell standard is used as the control sample and the ΔΔCt method is used for calculation. The calculation formula is ΔCt=Ct 基因标志物 –Ct 内参 , ΔΔCt=ΔCt 待测样本 –ΔCt 对照样本 , relative expression = 2 (-ΔΔCt) ; The iPSC residues were determined based on the significant relationship between the relative expression levels of SFRP2 or ZSCAN10 between the tested sample and the HEK293 cell standard.
[0016] In a second aspect of the present invention, a system for detecting iPSC residues in HEK293 cells is provided, comprising a first primer combination for detecting the SFRP2 gene, or a second primer combination for detecting the ZSCAN10 gene; the system further comprises a third primer combination for detecting the internal reference gene GAPDH; The nucleotide sequence of the first forward primer of the first primer combination is shown as SEQ ID NO.1, and the nucleotide sequence of the first reverse primer is shown as SEQ ID NO.2; the nucleotide sequence of the second forward primer of the second primer combination is shown as SEQ ID NO.3, and the nucleotide sequence of the second reverse primer is shown as SEQ ID NO.4; the nucleotide sequence of the third forward primer of the third primer combination is shown as SEQ ID NO.5, and the nucleotide sequence of the third reverse primer is shown as SEQ ID NO.6.
[0017] Furthermore, the above system also includes a third probe for detecting the internal reference gene GAPDH; When the system contains a first primer combination, it also includes a first probe; when the system contains a second primer combination, it also includes a second probe; the nucleotide sequence of the first probe is shown in SEQ ID NO.7, the nucleotide sequence of the second probe is shown in SEQ ID NO.8, and the nucleotide sequence of the third probe is shown in SEQ ID NO.9.
[0018] The third aspect of the present invention also provides an application of the above system in detecting residual iPSCs in HEK293 cells.
[0019] The fourth aspect of the present invention also provides a product for detecting residual iPSCs in HEK293 cells, comprising the above system.
[0020] Furthermore, the above-mentioned product is a detection kit, a detection test strip or a detection chip.
[0021] Compared with the prior art, the present invention is beneficial in that: 1. The present invention provides a new application of marker genes SFRP2 and ZSCAN10, which is used to detect iPSC residues in HEK293 cells. Compared with commonly used markers such as CNMD, IDO1, LIN28, hTERT, OCT4, SOX2, and NANOG, the gradient sample distinction is more obvious and the detection sensitivity is higher.
[0022] 2. By detecting the expression of marker genes SFRP2 and ZSCAN10 in iPSCs, 1×10 6 The detection sensitivity was 0.0001%, which was more sensitive than similar methods. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1-9 This is the amplification curve of the 9 genes to be tested as markers in Example 1.
[0024] Figure 10-12 This is the amplification curve of the three gene markers CNMD, SFRP2, and ZSCAN10 after the mixed cells were efficiently cultured in Example 2 (dye method).
[0025] Figure 13-15 This is the amplification curve of the three gene markers CNMD, SFRP2, and ZSCAN10 after the mixed cells were efficiently cultured in Example 2 (probe method).
[0026] Fig.16 The relative expression of the three gene markers in Example 2 and the significance test results (dye method).
[0027] Fig.17 The relative expression of the three gene markers in Example 2 and the significance test results (dye method). DETAILED DESCRIPTION
[0028] The technical solution of the present invention will be described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0029] The sources of reagents and raw materials used in the following specific embodiments are as follows: mTesR 1 culture medium: purchased from StemCell; Matrigel matrix glue: purchased from Corning; DMEM / F12 culture medium: purchased from Thermo Fisher Scientific (Gibco); Essential 8 culture medium: purchased from Thermo Fisher Scientific (Gibco); Laminin 521 recombinant protein: purchased from StemCell; Y27632: purchased from TargetMol; DPBS (without Ca 2+ Mg 2+ ): purchased from Thermo Fisher Scientific (Gibco); RNA extraction kit: purchased from Vazyme; Reversal kit: purchased from Accurate; qPCR reaction mix: purchased from Yeasen and Vazyme, respectively. The former is dye-based SYBR Mix and the latter is probe-based qPCR Mix. Ultrapure water: purchased from TAKARA; Induced pluripotent stem cells (iPSC): purchased from Beijing Saibei Biotechnology’s self-built iPSC cell bank; HEK293 cells: from the cell lines preserved by our company; Unless otherwise specified, primer sequences were synthesized by Wuhan Tianyi Huiyuan Biotechnology Co., Ltd., and probe sequences were synthesized by Sangon Biotechnology (Shanghai) Co., Ltd.
[0030] In the following specific embodiments, the present invention uses the following methods to screen gene markers and detect sensitivity: (1) First, potential target genes were selected as candidate gene markers, namely CNMD, IDO1, LIN28, SFRP2, ZSCAN10, hTERT, SOX2, OCT4, and NANOG. Primers for the marker genes were designed using GAPDH as an internal reference.
[0031] (2) In 1×10 6 After different proportions of iPSCs were added to HEK293 cells, namely 0.1%, 0.01%, 0.001%, and 0.0001%, conventional iPSC culture was performed, with Matriel as the culture matrix and mTesR 1 as the culture medium. qPCR was performed on the candidate gene markers, and several of them with the best amplification performance were selected as the final gene markers.
[0032] (3) In 1×10 6 Different proportions of iPSCs - 0.1%, 0.01%, 0.001%, and 0.0001% - were added to HEK293 cells, and then efficiently cultured (Laminin521 recombinant protein as culture matrix and Essential 8 as culture medium).
[0033] (4) For cells after efficient culture, qPCR reaction was performed using primer-probe combinations of corresponding gene markers to detect the expression levels of each marker gene in mixed cells with different iPSC incorporation ratios, and compared with 293 without iPSC incorporation. Finally, the lowest iPSC incorporation ratio that could be detected was determined based on the significance relationship, that is, the detection sensitivity was obtained.
[0034] Example 1: Screening of gene markers 1. Primer design.
[0035] First, we selected potential candidate gene markers related to induced pluripotent stem cells (iPSCs) (CNMD, IDO1, LIN28, SFRP2, ZSCAN10, hTERT), classic iPSC markers (OCT4, SOX2, NANOG), and GAPDH as an internal reference gene, and designed primers for these ten genes.
[0036] The upstream primer of GAPDH is shown in SEQ ID NO.5, and the downstream primer is shown in SEQ ID NO.6; The upstream primer of CNMD is shown in SEQ ID NO.10, and the downstream primer is shown in SEQ ID NO.11; The upstream primer of SFRP2 is shown in SEQ ID NO.1, and the downstream primer is shown in SEQ ID NO.2; The upstream primer of ZSCAN10 is shown in SEQ ID NO.3, and the downstream primer is shown in SEQ ID NO.4; The upstream primer of IDO1 is shown in SEQ ID NO.12, and the downstream primer is shown in SEQ ID NO.13; The upstream primer of LIN28 is shown in SEQ ID NO.14, and the downstream primer is shown in SEQ ID NO.15; The upstream primer of hTERT is shown in SEQ ID NO.16, and the downstream primer is shown in SEQ ID NO.17; The upstream primer of OCT4 is shown in SEQ ID NO.18, and the downstream primer is shown in SEQ ID NO.19; The upstream primer of SOX2 is shown in SEQ ID NO.20, and the downstream primer is shown in SEQ ID NO.21; The upstream primer of NANOG is shown as SEQ ID NO.22, and the downstream primer is shown as SEQ ID NO.23.
[0037] 2. Routine culture of mixed cells (1) Coat a six-well plate with 200 μL of Matrigel diluted with 1:1 (v / v) DMEM / F12 at least 1 hour in advance. Add 6 mL of DMEM / F12 culture medium to a 15 mL centrifuge tube; take a 200 μL aliquot of the diluted Matrigel and add it to the centrifuge tube. After gently pipetting 20 times to mix thoroughly, divide the Matrigel mixture evenly into each well of the six-well plate. Incubate the six-well plate at room temperature for 1 hour.
[0038] (2) After 1 h, aspirate the incubation liquid in the wells and add 2 mL of mTesR culture medium to each well. At the same time, add 2 μL of ROCK channel inhibitor Y-27632 to each well.
[0039] (3) Collect HEK293 cells and iPSC cells in the exponential growth phase, count them separately, and calculate 1×10 cells per well. 6Add HEK293 cells to 5 wells, mix well, and place in the incubator.
[0040] (4) Take 1×10 5 Add iPSC cells to the EP tube, fill it up to 200 μL with DMEM / F12, mark it as E5, gently pipette 30 times and set aside.
[0041] Prepare another 5 EP tubes, marked as 5E4, 5E3, 5E2, 5E1, 5E0, and add 900 μL DMEM / F12 to each tube. Pipette 100 μL of culture solution from E5 into 5E4 and gently pipette 30 times, then pipette 100 μL of culture solution from 5E4 into 5E3 and gently pipette 30 times, then pipette 100 μL of culture solution from 5E3 into 5E2 and gently pipette 30 times, then pipette 100 μL of culture solution from 5E2 into 5E1 and gently pipette 30 times, then pipette 100 μL of culture solution from 5E1 into 5E0 and gently pipette 30 times.
[0042] (5) Take out the well plate with HEK293 cells added in advance, mark 4 wells with E3, E2, E1, and E0 respectively, add 200 μL of the culture medium in tube 5E3 to well E3, add 200 μL of the culture medium in tube 5E2 to well E2, add 200 μL of the culture medium in tube 5E1 to well E1, and add 200 μL of the culture medium in tube 5E0 to well E0. That is, wells E3, E2, E1, and E0 contain 1×10 6 HEK293 cells, each containing 0.1×10 4 , 0.1×10 3 , 0.1×10 2 and 0.1×10 1 iPSC cells. Therefore, the incorporation ratios of iPSC cells were 0.1%, 0.01%, 0.001%, and 0.0001%, respectively. 100 μL of the culture medium in the E5 tube was added to the wells without HEK293 cells; then the well plate was returned to the incubator.
[0043] Thereafter, observe cell growth and change the medium every day, and collect cells on the 7th day for subsequent testing.
[0044] 3. Cell RNA extraction The cell RNA extraction process was carried out according to the instructions of the kit, and the process is as follows.
[0045] (1) Add the collected cells to Buffer RL at a rate of 5×10 6 Add 500 uL Buffer RL to each cell and vortex until no obvious cell clusters are observed. (2) Transfer the lysed sample to FastPure gDNA-Filter Columns III (FastPure gDNA-Filter Columns III has been placed in the collection tube) and centrifuge at 12,000 rpm (13,400 × g) for 30 seconds. Discard FastPure gDNA-Filter Columns III and collect the filtrate.
[0046] (3) Add 0.5 times the volume of anhydrous ethanol to the filtrate (for liver tissue samples, add 1 times the volume of 50% ethanol to the filtrate) and mix thoroughly. After adding ethanol, the solution becomes turbid or flocculent, which is normal. After shaking and mixing, you can proceed directly to the next step.
[0047] (4) Transfer the entire mixture from step (3) to FastPure RNA Columns III (FastPure RNA Columns III has been placed in the collection tube), centrifuge at 12,000 rpm (13,400 × g) for 30 sec, and discard the filtrate.
[0048] (5) Add 700 μL of Buffer RW1 to FastPure RNA Columns III, centrifuge at 12,000 rpm (13,400 × g) for 30 sec, and discard the filtrate.
[0049] (6) Add 700 μL of Bufer RW2 (with anhydrous ethanol) to FastPure RNA Columns III, centrifuge at 12,000 rpm (13,400 × g) for 30 sec, and discard the filtrate.
[0050] (7) Add 500 μL of Buffer RW2 (with anhydrous ethanol added) to FastPure RNA Columns III and centrifuge at 12,000 rpm (13,400 × g) for 2 min. Carefully remove the adsorption column from the collection tube to avoid contact with the filtrate, which may cause contamination.
[0051] (8) (Optional) If there is liquid remaining in the adsorption column or it comes into contact with the filtrate, discard the filtrate, return the FastPure RNA Columns III to the collection tube, and centrifuge at 12,000 rpm (13,400 × g) for 1 min to prevent ethanol contamination.
[0052] (9) Carefully transfer the adsorption column to a new RNase-free Collection Tubes 1.5 mL centrifuge tube, add 50-200 μL of RNase-free ddH2O to the center of the adsorption column, let it stand at room temperature for 1 min, and centrifuge at 12,000 rpm (13,400×g) for 1 min to elute the RNA. To increase the yield, RNase-free ddH2O can be preheated at 65°C in advance, added to the membrane, and left to stand at room temperature for 2-5 min; or centrifuge and perform a second elution.
[0053] (10) The extracted TotaI RNA can be used directly in downstream experiments or stored at -85~-65℃.
[0054] 4. RNA Reverse Transcription Add samples according to the following ratio: RNA 1 μg (calculate the required volume based on RNA concentration), 5×Evo M-MLVRT Master Mix 4 μL, RNase free water added to 20 μL.
[0055] The reaction program was: 37℃ for 15min; 85℃ for 5sec; 4℃ forever.
[0056] The cDNA of the reverse transcription product was uniformly diluted 10 times and used in the next experiment, or stored in a -80℃ refrigerator for future use.
[0057] 5. qPCR detection Add samples according to the following ratio: SYBR Green Master Mix 10 μL, Forward Primer 0.5 μL, Reverse Primer 0.5 μL, cDNA 1 μL, ddH2O 8 μL.
[0058] iPSCs were used as positive controls, and HEK293 cells without iPSCs were used as negative controls. The samples to be tested were marked as E3, E2, E1, and E0. A total of 9 genes to be tested, including CNMD, IDO1, LIN28, SFRP2, ZSCAN10, hTERT, OCT4, SOX2, and NANOG, were tested, and GAPDH was used as an internal reference. Three replicate wells were tested for each gene marker.
[0059] The reaction program was: first 95°C for 2 min; then 95°C for 10 sec, 58°C for 30 sec, for a total of 45 cycles.
[0060] Amplification curves Figure 1-9As shown in the figure, according to the amplification curve, we can see that the gradient samples of SOX2, OCT4, LIN28, and hTERT are least distinguished, while the gradient samples of CNMD, SFRP2, and ZSCAN10 are more clearly distinguished. Therefore, CNMD, SFRP2, and ZSCAN10 were selected as gene markers for subsequent detection after efficient culture.
[0061] Example 2: Detection of the expression of each gene marker after efficient cultivation
[0062] After preliminary screening, CNMD, SFRP2, and ZSCAN10 were selected as gene markers for detection after efficient culture, and probes were designed together with the internal reference GAPDH. All probes have a FAM fluorescent labeling group at the 5' end and a BHQ1 fluorescent quenching group at the 3' end.
[0063] The probe of SFRP2 is shown in SEQ ID NO.7; the probe of ZSCAN10 is shown in SEQ ID NO.8; the probe of CNMD is shown in SEQ ID NO.24; and the probe of GAPDH is shown in SEQ ID NO.9.
[0064] 2. Efficient culture of mixed cells (1) Coat a six-well plate with Laminin 521 recombinant protein at least 2 h in advance. 2+ and Mg 2+ Add 100 μL of DPBS to a 15 mL centrifuge tube; take a 300 μL aliquot of Laminin 521 and add it to the centrifuge tube. After gently blowing 20 times to mix thoroughly, divide the Laminin 521 mixture evenly into each well of the six-well plate. Incubate the six-well plate at 37°C for 2 h.
[0065] (2) After 2 h, remove the incubation liquid from the wells and add 2 mL of Essential 8 culture medium to each well. At the same time, add 2 μL of ROCK channel inhibitor Y-27632 to each well. (3) Collect HEK293 cells and iPSC cells in the exponential growth phase, count them separately, and calculate 1×10 cells per well. 6 Add HEK293 cells to 5 wells, mix well, and place in the incubator.
[0066] (4) Take 1×10 5 Add iPSC cells to the EP tube, fill it up to 200 μL with DMEM / F12, mark it as E5, gently pipette 30 times and set aside.
[0067] Prepare another 5 EP tubes, label them as 5E4, 5E3, 5E2, 5E1, 5E0, and add 900 μL DMEM / F12 to each tube. Pipette 100 μL of culture medium from E5 into 5E4 and gently pipette 30 times, then pipette 100 μL of culture medium into 5E3 and gently pipette 30 times, and so on.
[0068] (5) Take out the well plate with HEK293 cells added in advance, mark the four wells with E3, E2, E1, and E0 respectively, add 200 μL of the culture medium in tube 5E3 to well E3, add 200 μL of the culture medium in tube 5E2 to well E2, add 200 μL of the culture medium in tube 5E1 to well E1, and add 200 μL of the culture medium in tube 5E0 to well E0. Add 100 μL of the culture medium in tube E5 to the well without HEK293 cells; then put the well plate back into the incubator.
[0069] Thereafter, observe cell growth and change the medium every day, and collect cells on the 7th day for subsequent testing.
[0070] 3. Cell RNA extraction Cell RNA extraction was performed according to the kit instructions, and the process is as follows.
[0071] (1) Add the collected cells to Buffer RL, with a volume of <5×10 6 Add 500 μL Buffer RL per cell and vortex until no obvious cell clusters are observed.
[0072] (2) Transfer the lysed sample to FastPure gDNA-Filter Columns III (FastPure gDNA-Filter Columns III has been placed in the collection tube) and centrifuge at 12,000 rpm (13,400 × g) for 30 seconds. Discard FastPure gDNA-Filter Columns III and collect the filtrate.
[0073] (3) Add 0.5 times the volume of anhydrous ethanol to the filtrate (for liver tissue samples, add 1 times the volume of 50% ethanol to the filtrate) and mix thoroughly. After adding ethanol, the solution becomes turbid or flocculent, which is normal. After shaking and mixing, you can proceed directly to the next step.
[0074] (4) Transfer the entire mixture from step (3) to FastPure RNA Columns III (FastPure RNA Columns III has been placed in the collection tube), centrifuge at 12,000 rpm (13,400 × g) for 30 sec, and discard the filtrate.
[0075] (5) Add 700 μL of Buffer RW1 to FastPure RNA Columns III, centrifuge at 12,000 rpm (13,400 × g) for 30 sec, and discard the filtrate.
[0076] (6) Add 700 μL of Bufer RW2 (with anhydrous ethanol) to FastPure RNA Columns III, centrifuge at 12,000 rpm (13,400 × g) for 30 sec, and discard the filtrate.
[0077] (7) Add 500 μL of Buffer RW2 (with anhydrous ethanol added) to FastPure RNA Columns III and centrifuge at 12,000 rpm (13,400 × g) for 2 min. Carefully remove the adsorption column from the collection tube to avoid contact with the filtrate, which may cause contamination.
[0078] (8) (Optional) If there is liquid remaining in the adsorption column or it comes into contact with the filtrate, discard the filtrate, return the FastPure RNA Columns III to the collection tube, and centrifuge at 12,000 rpm (13,400 × g) for 1 min to prevent ethanol contamination.
[0079] (9) Carefully transfer the adsorption column to a new RNase-free Collection Tubes 1.5 mL centrifuge tube, add 50-200 μL of RNase-free ddH2O to the center of the adsorption column, let it stand at room temperature for 1 min, and centrifuge at 12,000 rpm (13,400×g) for 1 min to elute the RNA. To increase the yield, RNase-free ddH2O can be preheated at 65°C in advance, added to the membrane, and left to stand at room temperature for 2-5 min; or centrifuge and perform a second elution.
[0080] (10) The extracted TotaI RNA can be used directly in downstream experiments or stored at -85~-65℃.
[0081] 4. RNA Reverse Transcription Add samples according to the following ratio: RNA 1 μg (calculate the required volume based on RNA concentration), 5×Evo M-MLVRT Master Mix 4 μL, RNase free water added to 20 μL.
[0082] The reaction program was: 37℃ for 15min; 85℃ for 5sec; 4℃ forever.
[0083] The cDNA of the reverse transcription product was uniformly diluted 10 times and used in the next experiment, or stored in a -80℃ refrigerator for future use.
[0084] 5. qPCR detection The high-efficiency cultured cell samples were respectively subjected to target detection using the dye method and the probe method, and the relative expression of each target gene was analyzed.
[0085] The dye method was performed according to the following loading ratio: SYBR Green Master Mix 10 μL, Forward Primer 0.5 μL, Reverse Primer 0.5 μL, cDNA 1 μL, ddH2O 8 μL.
[0086] The dye method was carried out according to the following sample addition ratio: AceQ Universal U + Probe Master Mix V2 10μL, Forward Primer 0.4 μL, Reverse Primer 0.4 μL, Probe 0.2 μL, cDNA 1 μL, ddH2O 8μL.
[0087] iPSC was used as a positive control, and HEK293 without iPSC was used as a negative control. The samples to be tested were marked as E3, E2, E1, and E0. A total of three genes to be tested, including CNMD, SFRP2, and ZSCAN10, were tested, with GAPDH as an internal reference. Each target was tested in 5 replicate wells, and the internal reference was tested in 3 replicate wells.
[0088] The reaction program was: first 95°C for 2 min; then 95°C for 10 sec, 58°C for 30 sec, for a total of 45 cycles.
[0089] HEK293 cells were used as the control sample, GAPDH was used as the internal reference gene, and the ΔΔCt method was used for calculation. The calculation formula is: ΔCt=Ct 靶标 –Ct 内参 , ΔΔCt=ΔCt 待测样本 –ΔCt 对照样本 , relative expression = 2 (-ΔΔCt) .
[0090] The results are shown in Tables 1-6 below. A bar graph was drawn based on the results, and the significance between each concentration gradient sample and HEK293 was analyzed using an independent sample T test. Figure 9-17 shown.
[0091] Table 1 Results of residual detection of iPSC in HEK293 using SFRP2 (dye method)
[0092] Table 2 Results of iPSC residual detection in HEK293 using ZSCAN10 (dye method)
[0093] Table 3 Results of iPSC residual detection in HEK293 using CNMD (dye method)
[0094] Table 4 Results of residual detection of iPSC in HEK293 using SFRP2 (dye method)
[0095] Table 5 Results of iPSC residual detection in HEK293 using ZSCAN10 (dye method)
[0096] Table 6 Results of iPSC residual detection in HEK293 using CNMD (dye method)
[0097] From the test results, we can see that the significance of CNMD can reach iPSC-E2 (0.01% iPSC), the significance of SFRP2 can reach iPSC-E0 (0.0001% iPSC) in the dye method, and the significance of ZSCAN10 can reach iPSC-E0 (0.0001% iPSC) in both methods. Although the significance of CNMD can only reach 0.01% iPSC incorporation, CNMD is not expressed in the background cell 293, and its results will not be affected by the background cells, so it is also a target with great application prospects.
[0098] In summary, the present invention relates to a novel primer-probe combination and a detection method thereof, which can distinguish 0.0001% iPSC incorporation from HEK293 cells and has high detection sensitivity.
[0099] It should be noted that the description of the above embodiments is only used to understand the method of the present invention and its core idea. It should be pointed out that the present invention is not limited to the specific details in the above embodiments. For those skilled in the art, without departing from the principle of the present invention, several improvements and modifications can be made to the present invention, and these improvements and modifications will also fall within the scope of protection of the claims of the present invention.
Claims
1. A method for detecting residual iPSCs in HEK293 cells, characterized in that: The steps include: Extracting RNA from cells in the sample to be tested, reverse transcribing the RNA to obtain reverse transcription product cDNA, and performing qPCR amplification on the cDNA; Design a first primer combination and a first probe for detecting the gene SFRP2, design a second primer combination and a second probe for detecting the gene ZSCAN10, and design a third primer combination and a third probe for detecting the internal reference gene GAPDH; The expression of the gene SFRP2 in the qPCR amplification product is detected using the first primer combination and the first probe, or the expression of the gene ZSCAN10 in the qPCR amplification product is detected using the second primer combination and the second probe; the expression of the internal reference gene GAPDH in the qPCR amplification product is detected using the third primer combination and the third probe; The expression levels of SFRP2 or ZSCAN10 in the sample to be tested and the HEK293 cell standard were calculated, and the gene GAPDH was used as the internal reference gene to compare the expression difference of SFRP2 or ZSCAN10 between the sample to be tested and the HEK293 cell standard to determine the residual situation of iPSC in the sample to be tested; The nucleotide sequence of the first forward primer of the first primer combination is shown as SEQ ID NO.1, and the nucleotide sequence of the first reverse primer is shown as SEQ ID NO.2; the nucleotide sequence of the second forward primer of the second primer combination is shown as SEQ ID NO.3, and the nucleotide sequence of the second reverse primer is shown as SEQ ID NO.4; the nucleotide sequence of the third forward primer of the third primer combination is shown as SEQ ID NO.5, and the nucleotide sequence of the third reverse primer is shown as SEQ ID NO.
6.
2. The method for detecting residual iPSCs in HEK293 cells according to claim 1, characterized in that: When the dye method is used for detection, the first primer combination is used to detect the expression of the SFRP2 gene, or the second primer combination is used to detect the expression of the gene ZSCAN10; the third primer combination is used to detect the expression of the internal reference gene GAPDH; When the probe method is used for detection, the first primer combination and the first probe are used to detect the expression of the gene SFRP2, or the second primer combination and the second probe are used to detect the expression of the gene ZSCAN10; the third primer combination and the third probe are used to detect the expression of the internal reference gene GAPDH; the nucleotide sequence of the first probe is shown in SEQ ID NO.7, the nucleotide sequence of the second probe is shown in SEQ ID NO.8, and the nucleotide sequence of the third probe is shown in SEQ ID NO.
9.
3. The method for detecting residual iPSCs in HEK293 cells according to claim 2, characterized in that: HEK293 cell standard was used as the control sample and the ΔΔCt method was used for calculation. The calculation formula is ΔCt=Ct 基因标志物 –Ct 内参 , ΔΔCt=ΔCt 待测样本 –ΔCt 对照样本 , relative expression = 2 (-ΔΔCt) ; The iPSC residues were determined based on the significant relationship between the relative expression levels of SFRP2 or ZSCAN10 between the tested sample and the HEK293 cell standard.
4. A system for detecting residual iPSCs in HEK293 cells, characterized in that: The system includes a first primer combination for detecting the SFRP2 gene, or a second primer combination for detecting the ZSCAN10 gene; the system also includes a third primer combination for detecting the internal reference gene GAPDH; The nucleotide sequence of the first forward primer of the first primer combination is shown as SEQ ID NO.1, and the nucleotide sequence of the first reverse primer is shown as SEQ ID NO.2; the nucleotide sequence of the second forward primer of the second primer combination is shown as SEQ ID NO.3, and the nucleotide sequence of the second reverse primer is shown as SEQ ID NO.4; the nucleotide sequence of the third forward primer of the third primer combination is shown as SEQ ID NO.5, and the nucleotide sequence of the third reverse primer is shown as SEQ ID NO.
6.
5. The system for detecting residual iPSCs in HEK293 cells according to claim 4, characterized in that: Also included is a third probe for detecting an internal reference gene GAPDH; When the system contains a first primer combination, it also includes a first probe; when the system contains a second primer combination, it also includes a second probe; the nucleotide sequence of the first probe is shown in SEQ ID NO.7, the nucleotide sequence of the second probe is shown in SEQ ID NO.8, and the nucleotide sequence of the third probe is shown in SEQ ID NO.
9.
6. Use of the system according to claim 4 or 5 in detecting residual iPSCs in HEK293 cells.
7. A product for detecting residual iPSC in HEK293 cells, characterized in that: Comprising the system of claim 4 or 5.
8. The product for detecting residual iPSCs in HEK293 cells according to claim 7, characterized in that: The product is a detection kit, a detection test strip or a detection chip.
